Five Key Startups Shining the Light on Rare Diseases

Five Key Startups Shining the Light on Rare Diseases

Growing product pipelines and government support for rare disease treatments is expected to drive the growth of the global market by 11.6% per year from $216.2 billion in 2024 to $374.4 billion by 2030. Many rare disease treatments in the market are biologics, with one example being Sanofi’s Dupixent (dupilumab), which was greenlit by the U.S. Food and Drug Administration (FDA) in June this year for the treatment of adult patients with a conditi…